SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-24-001140
Filing Date
2024-09-19
Accepted
2024-09-19 16:30:20
Documents
4

Document Format Files

Seq Description Document Type Size
1 e663897_f6pos-biodexa.htm F-6 POS 57125
2 e663897_ex99-a2.htm EX-99.(A)(2) 156571
3 e663897_ex99-e.htm EX-99.(E) 2608
4 GRAPHIC image001.jpg GRAPHIC 64068
  Complete submission text file 0001193805-24-001140.txt   306318
Mailing Address 383 MADISON AVENUE 11TH FLOOR NEW YORK NY 10179
Business Address 383 MADISON AVENUE 11TH FLOOR NEW YORK NY 10179 212-319-7600
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by) CIK: 0001474274 (see all company filings)

IRS No.: 000000000 | State of Incorp.: OH | Fiscal Year End: 1231
Type: F-6 POS
SIC: 8880 American Depositary Receipts
(CF Office: International Corp Fin)

Mailing Address 120 BROADWAY 32ND FLOOR NEW YORK NY 10271
Business Address 120 BROADWAY 32ND FLOOR NEW YORK NY 10271 12122383128
Biodexa Pharmaceuticals PLC/ADR (Subject) CIK: 0001832898 (see all company filings)

IRS No.: 000000000
Type: F-6 POS | Act: 33 | File No.: 333-275909 | Film No.: 241310748
(CF Office: International Corp Fin)